QGEN

#965
QIAGEN N.V.
41.13 USD
-1.25%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
41.04
41.51
Range Annuel
38.80
57.82
Changement quotidien
-1.25%
Changement Mensuel
+0.56%
Evolution sur 6 mois
-14.42%
Changement Annuel
+1.16%
Clôture Précédente
41.65
Open
41.50
Bid
Ask
Low
41.04
High
41.51
Volume
161
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
  • Market Capitalization 8.92 B
  • Employee 5 654
  • Founded 1984
  • CEO Thierry Bernard
  • Website www.qiagen.com
  • Headquarter Netherlands
  • FIGI UNKNOWN
  • Industry Diagnostic et Recherche
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents
Dividends per share
0.25
Dividend yield %
0.56

Qiagen N.V

QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer.

Nouvelles